We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Barr Gets FDA Green Light For Allegra-D Amid Patent Dispute

Law360 (April 15, 2005, 12:00 AM EDT) -- The U.S. Food and Drug Administration has granted Barr Laboratories a final approval for a generic version of Aventis Pharmaceuticals' blockbuster allergy medicine Allegra-D, the company said.

The move would give Barr the right to make a generic version of the 12-hour 60mg and 120 mg extended-release tablets if the company prevails in a patent challenge against the French drug maker.

Barr is the first applicant to file an abbreviated New Drug Application containing a paragraph IV patent challenge on the patents relating to the Allegra-D...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.